← Back to Analyst Consensus 
GEHC Buy
GE HealthCare Technologies Inc.
Current Price —
Implied Upside —
Analysts 27
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 3 reiterations from 4 firms
Next Earnings
Oct 28, 2026 (2 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Oct 7, 2026 | Barclays | initiate | — → Overweight | — | 53% |
| Oct 5, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Oct 5, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Sep 22, 2026 | Needham | initiate | — → Buy | — | 50% |
| Sep 17, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Aug 19, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jul 31, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jul 30, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Jul 30, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jul 30, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Jul 29, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jul 17, 2026 | Hovde Group | initiate | — → Market Perform | — | 68% |
| Jul 16, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jul 9, 2026 | BMO Capital | initiate | — → Market Perform | — | 53% |
| Jun 23, 2026 | RBC Capital | initiate | — → Outperform | — | 55% |
| May 21, 2026 | UBS | upgrade | Sell → Neutral | — | 54% |
| Apr 30, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Apr 30, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Apr 30, 2026 | Goldman Sachs | downgrade | Buy → Neutral | — | 54% |
| Apr 30, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Apr 30, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Apr 30, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Apr 29, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Apr 21, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Apr 17, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Apr 13, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Apr 9, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Apr 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Mar 26, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Mar 19, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 11, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Feb 9, 2026 | BTIG | reiterate | Buy → Buy | $91 | 52% |
| Feb 6, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | $87 | 53% |
| Feb 5, 2026 | Stifel | maintain | Buy → Buy | $98 | 53% |
| Feb 5, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $98 | 58% |
| Feb 5, 2026 | Wells Fargo | maintain | Overweight → Overweight | $97 | 54% |
| Feb 5, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $85 | 54% |
| Feb 4, 2026 | BTIG | maintain | Buy → Buy | $91 | 52% |
| Jan 30, 2026 | Piper Sandler | maintain | Overweight → Overweight | $94 | 54% |
| Jan 15, 2026 | UBS | downgrade | Neutral → Sell | $77 | 54% |
| Jan 7, 2026 | Stifel | maintain | Buy → Buy | $95 | 53% |
| Jan 5, 2026 | B of A Securities | maintain | Neutral → Neutral | $92 | 53% |
| Dec 11, 2025 | Citigroup | maintain | Neutral → Neutral | $88 | 54% |
| Dec 11, 2025 | Jefferies | maintain | Buy → Buy | $105 | 52% |
| Nov 21, 2025 | BTIG | reiterate | Buy → Buy | $87 | 52% |
| Oct 30, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $80 | 54% |
| Oct 30, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $92 | 58% |
| Oct 30, 2025 | Wells Fargo | maintain | Overweight → Overweight | $87 | 54% |
| Oct 13, 2025 | BTIG | maintain | Buy → Buy | $89 | 52% |
Price Target Trend
Jul 26, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days